home / stock / medxf / medxf quote
Last: | $1.645 |
---|---|
Change Percent: | -9.42% |
Open: | $1.51 |
Close: | $1.645 |
High: | $1.69 |
Low: | $1.51 |
Volume: | 47,935 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.645 | $1.51 | $1.645 | $1.69 | $1.51 | 47,935 | 07-05-2024 |
$1.38 | $1.38 | $1.38 | $1.38 | $1.38 | 200 | 07-04-2024 |
$1.38 | $1.38 | $1.38 | $1.38 | $1.38 | 200 | 07-03-2024 |
$1.32 | $1.3503 | $1.32 | $1.3503 | $1.32 | 7,325 | 07-02-2024 |
$1.3503 | $1.3503 | $1.3503 | $1.3503 | $1.3503 | 1,094 | 07-01-2024 |
$1.33 | $1.29 | $1.33 | $1.33 | $1.29 | 11,191 | 06-28-2024 |
$1.2727 | $1.28 | $1.2727 | $1.28 | $1.2603 | 6,700 | 06-27-2024 |
$1.26 | $1.2601 | $1.26 | $1.2685 | $1.26 | 3,820 | 06-26-2024 |
$1.26 | $1.24 | $1.26 | $1.26 | $1.23 | 8,119 | 06-25-2024 |
$1.235 | $1.26 | $1.235 | $1.26 | $1.23 | 4,619 | 06-24-2024 |
$1.21 | $1.18 | $1.21 | $1.21 | $1.18 | 10,650 | 06-21-2024 |
$1.19 | $1.18 | $1.19 | $1.19 | $1.18 | 458 | 06-20-2024 |
$1.165 | $1.1625 | $1.165 | $1.175 | $1.16 | 25,010 | 06-19-2024 |
$1.165 | $1.1625 | $1.165 | $1.175 | $1.16 | 25,010 | 06-18-2024 |
$1.15 | $1.137 | $1.15 | $1.15 | $1.1328 | 6,455 | 06-17-2024 |
$1.1425 | $1.165 | $1.1425 | $1.175 | $1.115 | 39,600 | 06-14-2024 |
$1.18 | $1.16 | $1.18 | $1.18 | $1.155 | 16,100 | 06-13-2024 |
$1.213 | $1.21 | $1.213 | $1.213 | $1.21 | 3,330 | 06-12-2024 |
$1.194 | $1.18 | $1.194 | $1.194 | $1.1658 | 12,781 | 06-11-2024 |
$1.2 | $1.32 | $1.2 | $1.355 | $1.1 | 38,036 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Medexus Pharmaceuticals Inc Company Name:
MEDXF Stock Symbol:
OTCMKTS Market:
Medexus Pharmaceuticals Inc Website:
FDA has Accepted for Review the Treosulfan NDA Management to host conference call at 8:00 AM Eastern time on Wednesday, June 26, 2024 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 25, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced its operating and...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 18, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Wednesday, June 26, 2024 to discuss Medexus's results for its fourth fiscal quarter and fiscal year ended Mar...
2024-06-06 12:08:44 ET In the United States, a new drug application, or NDA, is the vehicle through which drug sponsors formally propose that the FDA approve a new %Pharmaceutical for sale and marketing. And news that the FDA has accepted this firm’s resubmission is sending share...